DNB Bioteknologi
DNB Bioteknologi is an equity fund which primarily invests in shares listed on stock exchanges and regulated markets across the world.
Actively managed equity fund
Invests in vaccines, medicines and diagnostics
You can buy DNB Bioteknologi using a computer or in the Spare app
DNB Bioteknologi
The fund mainly invests in the following sectors:
- Biotechnology
- Diagnostics
- Pharmacy
- Production of pharmaceutical products
- Biological medicines including gene therapy
- Other health-related businesses
Read more about DNB Bioteknologi (DNB Biotechnology)
Minimum purchase amount is NOK 100. With a savings scheme in mutual funds, your savings happen automatically every month.
DNB Biotechnology management team
The health funds in DNB Asset Management are managed by a team with extensive experience in medicine and finance, consisting of:
- Benedicte Kilander Bakke
- Rune Sand
- Anesa Mulabecirovic Sahnoun
Benedicte is a qualified dentist in addition to being an authorised financial analyst (AFA) with an MBA in Finance, Rune has a master’s degree in Finance and also an AFA and an MBA in Finance, and Anesa is a medic with a doctorate in medicine and also has an MBA in Finance.
Equity fund
Equity funds are suitable for people who want to save for more than six years and who can tolerate volatility in value in the meantime.
